Prana biotechnology limited

Prana biotechnology limited

Pr mjff 22aug11changes v2 final for usDrugs to treat Parkinsons disease is approximately 4 billion per year however most currently available drugs primarily treat the symptoms and do not actually prevent the ongoing destruction of the substantia nigra in the brain and progression of the disease The program grant title isPBT434 a novel neuroprotective drug for Parkinsons Disease completion of preclinical studies to enable human clinical trialsAbout Prana Biotechnology Limited Prana Biot Source: Prana biotechnology limited
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s